Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681.3K

Citius Pharmaceuticals reports 2018 executive compensation

Published: December 20, 2018

Citius Pharmaceuticals reported fiscal year 2018 executive compensation information on December 20, 2018.

In 2018, three executives at Citius Pharmaceuticals received on average a compensation package of $512.9K, a 6% increase compared to previous year.

Average pay of disclosed executives at Citius Pharmaceuticals

Myron Holubiak, Chief Executive Officer, received $681.3K in total, which decreased by 2% compared to 2017. 66.05% of Holubiak's compensation, or $450K, was in salary. Holubiak also received $186.8K in non-equity incentive plan and $44.6K in option awards.

Jaime Bartushak, Chief Financial Officer, received a compensation package of $459K, which increased by 1% compared to previous year. 54.47% of the compensation package, or $250K, was in salary.

Leonard Mazur, Chairman, earned $398.3K in 2018, a 30% increase compared to previous year.

Citius Pharmaceuticals' fiscal year ends on September 30.